Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer-Reference-Cited by-同舟云学术

Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer

Published:2022-05-17 Issue:7 Volume:113 Page:2386-2396
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Shiota Masaki¹^ORCID,Takamatsu Dai¹,Kimura Takahiro²,Tashiro Kojiro²,Matsui Yoshiyuki³,Tomida Ryotaro⁴,Saito Ryoichi⁵,Tsutsumi Masakazu⁶,Yokomizo Akira⁷,Yamamoto Yoshiyuki⁸,Edamura Kohei⁹,Miyake Makito¹⁰^ORCID,Morizane Shuichi¹¹,Yoshino Takayuki¹²,Matsukawa Akihiro¹³,Narita Shintaro¹⁴^ORCID,Matsumoto Ryuji¹⁵,Kasahara Takashi¹⁶,Hashimoto Kohei¹⁷,Matsumoto Hiroaki¹⁸^ORCID,Kato Masashi¹⁹,Akamatsu Shusuke²⁰,Joraku Akira²¹,Kato Manabu²²,Yamaguchi Takahiro²³,Saito Toshihiro²⁴,Kaneko Tomoyuki²⁵,Takahashi Atsushi²⁶,Kato Takuma²⁷,Sakamoto Shinichi²⁸^ORCID,Enokida Hideki²⁹^ORCID,Kanno Hidenori³⁰,Terada Naoki³¹,Suekane Shigetaka³²^ORCID,Nishiyama Naotaka³³,Eto Masatoshi¹,Kitamura Hiroshi³³,

Affiliation:

1. Department of Urology Kyushu University Fukuoka Japan

2. Department of Urology The Jikei University School of Medicine Tokyo Japan

3. Department of Urology National Cancer Center Hospital Tokyo Japan

4. Department of Urology Shikoku Cancer Center Matsuyama Japan

5. Department of Urology and Andrology Kansai Medical University Osaka Japan

6. Department of Urology Hitachi General Hospital Hitachi Japan

7. Department of Urology Harasanshin Hospital Fukuoka Japan

8. Department of Urology Osaka International Cancer Institute Osaka Japan

9. Department of Urology Okayama University Okayama Japan

10. Department of Urology Nara Medical University Kashihara Japan

11. Division of Urology Department of Surgery Faculty of Medicine Tottori University Yonago Japan

12. Department of Urology University of Tsukuba Tsukuba Japan

13. Department of Urology Kashiwa Hospital The Jikei University Chiba Japan

14. Department of Urology Akita University Akita Japan

15. Department of Renal and Genitourinary Surgery Hokkaido University Sapporo Japan

16. Division of Urology Department of Regenerative and Transplant Medicine Niigata University Niigata Japan

17. Department of Urology Sapporo Medical University Sapporo Japan

18. Department of Urology Yamaguchi University Ube Japan

19. Department of Urology Nagoya University Nagoya Japan

20. Department of Urology Kyoto University Kyoto Japan

21. Department of Urology Ibaraki Prefectural Central Hospital Ibaraki Cancer Center Kasama Japan

22. Department of Nephro‐Urologic Surgery and Andrology Mie University Tsu Japan

23. Department of Urology Kumamoto University Kumamoto Japan

24. Department of Urology Niigata Cancer Center Hospital Niigata Japan

25. Department of Urology Teikyo University School of Medicine Tokyo Japan

26. Department of Urology Hakodate Goryoukaku Hospital Hakodate Japan

27. Department of Urology Kagawa University Kagawa Japan

28. Department of Urology Chiba University Chiba Japan

29. Department of Urology Kagoshima University Kagoshima Japan

30. Department of Urology Yamagata University Yamagata Japan

31. Department of Urology Miyazaki University Miyazaki Japan

32. Department of Urology Kurume University School of Medicine Kurume Japan

33. Department of Urology University of Toyama Toyama Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15383

Reference23 articles.

1. Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer

2. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial

3. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

4. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

5. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement;International Journal of Clinical Oncology;2024-07-08

2. Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer;Prostate International;2024-03

3. Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort;International Journal of Urology;2024-02-29

4. ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy;Annals of Surgical Oncology;2024-02-19

5. Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy;Annals of Surgical Oncology;2024-02-14